SM
TPST icon

Sabby Management’s Tempest Therapeutics TPST Stock Holding History

Sabby Management’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$568K Buy
511,286
+493,430
+2,763% +$814K 0.51% 12
2026
Q1 		$29.3K Sell
17,856
-160,736
-90% -$388K 0.07% 26
2025
Q4 		$513K Buy
+178,592
New +$1.26M 0.74% 12
2025
Q3 		– Sell
-276,587
Closed -$1.88M – 61
2025
Q2 		$1.88M Buy
+276,587
New +$1.97M 3.41% 5
2018
Q4 		– Sell
-87
Closed -$187K – 141
2018
Q3 		$187K Sell
87
-239
-73% -$574K 0.02% 95
2018
Q2 		$866K Sell
326
-174
-35% -$458K 0.13% 65
2018
Q1 		$1.19M Buy
500
+295
+144% +$884K 0.14% 56
2017
Q4 		$840K Buy
205
+17
+9% +$71.3K 0.08% 84
2017
Q3 		$781K Buy
188
+14
+8% +$59.8K 0.05% 87
2017
Q2 		$795K Buy
174
+29
+20% +$123K 0.05% 111
2017
Q1 		$792K Buy
145
+128
+753% +$596K 0.04% 144
2016
Q4 		$74K Hold
17
– – ﹤0.01% 276
2016
Q3 		$358K Sell
17
-29
-63% -$525K 0.01% 247
2016
Q2 		$704K Buy
+46
New +$1.05M 0.04% 194
2015
Q4 		– Sell
-102
Closed -$3.36M – 367
2015
Q3 		$2.53M Sell
102
-19
-16% -$1.28M 0.1% 132
2015
Q2 		$10.3M Sell
121
-588
-83% -$53.9M 0.37% 56
2015
Q1 		$4.69M Buy
+709
New +$94.4M 0.2% 84
2014
Q3 		– Sell
-62
Closed -$1.66M – 296
2014
Q2 		$1.66M Sell
62
-60
-49% -$1.41M 0.07% 115
2014
Q1 		$3.19M Buy
122
+70
+135% +$1.98M 0.18% 81
2013
Q4 		$1.39M Sell
52
-3
-5% -$82.3K 0.09% 99
2013
Q3 		$1.6M Buy
+55
New +$1.95M 0.1% 97

Other funds holding TPST

VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Sabby Management's TPST Position: Q2 2026 in Review

Sabby Management increased its Tempest Therapeutics (TPST) stake by 2,763% in Q2 2026, buying an estimated $814K and bringing the position to 511,286 shares worth $568K. The position accounts for 0.51% of the portfolio, ranked #12.

Sabby Management first reported a position in TPST in Q3 2013 and has held it in 21 quarters since. The position peaked at $10.3M in Q2 2015. 21 funds tracked by Wall St. Rank hold TPST as of Q2 2026.

  • Sabby Management held 511,286 shares of Tempest Therapeutics worth $568K as of Q2 2026.
  • Sabby Management bought 493,430 Tempest Therapeutics shares in Q2 2026, an estimated $814K.
  • Tempest Therapeutics made up 0.51% of Sabby Management's portfolio in Q2 2026, its #12 holding.
  • Sabby Management first reported a position in Tempest Therapeutics in Q3 2013 and has held it in 21 quarters since.
  • Sabby Management's Tempest Therapeutics position peaked at $10.3M in Q2 2015.
  • 21 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2026.

Based on Sabby Management's 13F filing for Q2 2026, filed 14 Aug 2026.